Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01032148. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers
ClinicalTrials.gov study NCT00262210. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
ClinicalTrials.gov study NCT00069966. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00002522. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04067037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07225985. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable
ClinicalTrials.gov study NCT00876122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01647971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01388959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT06045195. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT05155839. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00794638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05991388. IPD Sharing: NO. Countries: 7. Publications: 0.
RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy
ClinicalTrials.gov study NCT04827862. IPD Sharing: NO. Countries: 1. Publications: 0.
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01000753. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04897477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
ClinicalTrials.gov study NCT05363800. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT05169489. IPD Sharing: YES. Countries: 1. Publications: 0.
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)
ClinicalTrials.gov study NCT06446128. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.